GENE ONLINE|News &
Opinion
Blog

AstraZeneca
Trials & Approvals AstraZenecaEosinophilic Asthma
China Approves AstraZeneca’s Fasenra for Severe Eosinophilic Asthma
2024-08-21
Asia-Pacific ADCManufacturingAstraZeneca
AstraZeneca’s $1.5 Billion ADC Manufacturing Facility in Singapore
2024-05-23
Manufacturing Novo NordiskJohnson & JohnsonAmgenBristol Myers SquibbAstraZenecaMerck KGaAModernaDaiichi Sankyo
Pharmaceutical Giants Expand Research and Manufacturing Capabilities, Fueling 2024 Innovation and Growth
2024-03-01
Manufacturing Type 2 Diabetes
AstraZeneca Invests $26.5 Million in New Production Line for Diabetes Drug in China
2024-01-19
JPM 2024 JP Morgan 2024
JPM 2024: AZ, Ginkgo and Moderna Provides Business Updates, Illustrating Optimistic Prospects
2024-01-11
Regulatory AstraZenecaAsthma
AstraZeneca’s severe asthma drug Tezspire has been granted market authorization in South Korea
2023-12-25
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Sept 25-Sept 29
2023-10-03
Trials & Approvals RSV vaccines
Sanofi and AstraZeneca’s RSV Antibody Drug Gets FDA Approval, Adding New Weapon for Preventing Infant Infections
2023-07-18
Deals RSVMonoclonal Antibody
Sobi Enters Into New Royalty Agreement on RSV Antibody Drug Nirsevimab With Sanofi
2023-04-11
Trials & Approvals Heart Failure
AstraZeneca’s Forxiga Gets EU Nod To Treat Symptomatic Chronic Heart Failure
2023-02-08
M&A JPM
JPM23: Acquisition Announcements From JP Morgan Healthcare Conference 2023 Day One
2023-01-10
Special Healthcare Industry
GeneOnline’s Pick: Top 10 Industry News Stories in 2022
2022-12-26
M&A AstraZenca
AstraZeneca Expands Oncology Portfolio with $320 Million Neogene Acquisition
2022-11-29
COVID-19 AstraZeneca
Sanofi, GSK Secure European COVID-19 Booster Approval, AstraZeneca Withdraws U.S. Application
2022-11-10
COVID-19 AstraZeneca
AstraZeneca’s COVID-19 Vaccine Finally Wins Full Authorization in the European Union
2022-11-01
1 2 3
LATEST
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
Illumina’s IVD Biomarker Test Becomes the First FDA-approved Pan-cancer Companion Diagnostics Kit
2024-09-11
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
READ MORE
EVENT
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-10
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top